In Brief: SBI continuous glucose monitor
This article was originally published in The Gray Sheet
Executive Summary
SBI continuous glucose monitor: Synthetic Blood International elects Gerald Schlatter president of newly established Implanted BioSystems subsidiary. Former chief operating officer of Synthetic, Schlatter will lead the development and commercialization of the firm's battery-powered Implanted Glucose BioSensor device. Schlatter has "more that 25 years' experience with American Hospital Supply" and Xerox' medical products division, the company says...